About us

The guidance development is led by: 

• Lucy Galloway 
  Consultant Pharmacist Genomic Medicine and Pharmacy Lead 
  NHS South East Genomic Medicine Service 
• Dr Hayley Wickens 
  Consultant Pharmacist Genomic Medicine and Pharmacy Lead
  NHS Central and South Genomic Medicine Service 

All information provided within the Handbook has been compiled from a range of sources and written by pharmacist members of the UK Clinical Pharmacy Association (UKCPA) with expertise in pharmacogenomics.

All content is reviewed prior to publication by an independent healthcare professional with expertise in pharmacogenetics to ensure the accuracy and practicality of the application of the information. A full list of contributors can be found here.

All the content of the Handbook is under a schedule of regular review. The frequency of review is between one and five years, depending on the medication, in order to allow for more contentious or complex medications to be reviewed more regularly. If new guidelines, position statements, or evidence prompts an earlier review, this is highlighted in a banner at the top of the page.

All reasonable precautions have been taken by the contributors to verify the content published in this Handbook. The ultimate responsibility for the use of advice mentioned in the Handbook and in the interpretation of published material lies with the practitioner; the contributors, editors and publishers can accept no liability whatsoever in respect of any claim for damages arising therefrom. Please inform the contributors of any issues via the contact page.